Focus Partners Advisor Solutions’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$484K Sell
11,354
-971
-8% -$43.4K ﹤0.01% 828
2026
Q1
$594K Buy
12,325
+442
+4% +$20.6K 0.01% 731
2025
Q4
$576K Sell
11,883
-162
-1% -$8.03K 0.01% 675
2025
Q3
$574K Buy
12,045
+101
+0.8% +$4.87K 0.01% 689
2025
Q2
$577K Sell
11,944
-137
-1% -$7K 0.01% 624
2025
Q1
$670K Buy
12,081
+1,667
+16% +$90.2K 0.01% 501
2024
Q4
$502K Buy
+10,414
New +$530K 0.01% 473

Other funds holding SNY

Focus Partners Advisor Solutions's SNY Position: Q2 2026 in Review

Focus Partners Advisor Solutions reduced its Sanofi (SNY) stake by 7.9% in Q2 2026, selling an estimated $43.4K and leaving 11,354 shares worth $484K. The position accounts for ﹤0.01% of the portfolio, ranked #828.

Focus Partners Advisor Solutions first reported a position in SNY in Q4 2024 and has held it in 7 quarters since. The position peaked at $670K in Q1 2025. 715 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Focus Partners Advisor Solutions held 11,354 shares of Sanofi worth $484K as of Q2 2026.
  • Focus Partners Advisor Solutions sold 971 Sanofi shares in Q2 2026, an estimated $43.4K.
  • Sanofi made up ﹤0.01% of Focus Partners Advisor Solutions's portfolio in Q2 2026, its #828 holding.
  • Focus Partners Advisor Solutions first reported a position in Sanofi in Q4 2024 and has held it in 7 quarters since.
  • Focus Partners Advisor Solutions's Sanofi position peaked at $670K in Q1 2025.
  • 715 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Focus Partners Advisor Solutions's 13F filing for Q2 2026, filed 6 Aug 2026.